These findings indicate a potential link between COX-2 and obesity and MASLD pathogenesis (10, 11) and suggest that inhibition of COX-2 may be an effective strategy in managing MASLD. The gene discussed is PTGS2; the disease is obesity due to melanocortin 4 receptor deficiency.